SK Biopharmaceuticals Co., Ltd. (KRX: 326030)
South Korea flag South Korea · Delayed Price · Currency is KRW
103,300
-200 (-0.19%)
Nov 15, 2024, 3:30 PM KST

SK Biopharmaceuticals Market Cap

SK Biopharmaceuticals has a market cap or net worth of 7.93 trillion as of November 18, 2024. Its market cap has increased by 31.60% in one year.

Market Cap
7.93T
Enterprise Value
7.88T
Revenue
465.06B
Ranking
n/a
PE Ratio
234.74
Stock Price
103,300.00

Market Cap Chart

Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.93T, a decrease of -20.31%. That is a compound annual growth rate of -5.05%.

History

DateMarket Cap% Change
Nov 18, 20247,925.30B0.80%
Dec 28, 20237,862.65B39.25%
Dec 29, 20225,646.39B-25.82%
Dec 30, 20217,612.05B-42.49%
Dec 30, 202013.23T33.07%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition